# Gene Synthesis Market Size, Share, Analysis and Forecast 2024-2032
IMARC Group's report titled "**Gene Synthesis Market by Method (Solid-Phase Synthesis, Chip-Based Synthesis, PCR-Based Enzyme Synthesis), Services (Antibody DNA Synthesis, Viral DNA Synthesis, and Others), Application (Gene and Cell Therapy Development, Vaccine Development, Disease Diagnosis, and Others), End Use (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations), and Region 2024-2032**", The [global gene synthesis market size](https://www.imarcgroup.com/gene-synthesis-market) reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.58% during 2024-2032.2032.

**For an in-depth analysis, you can refer sample copy of the report:** <https://www.imarcgroup.com/gene-synthesis-market/requestsample>

**Factors Affecting the Growth of the Gene Synthesis Industry:**

- **Advancements in Biotechnology:**

Breakthroughs in gene editing technologies, such as CRISPR-Cas9, are revolutionizing the field of biotechnology. These advancements enable precise modification of genetic material, leading to the development of novel therapies, genetically engineered organisms, and customized DNA sequences, which require gene synthesis services. Innovations in gene synthesis techniques are leading to improvements in efficiency and accuracy. Modern synthesis platforms utilize high-throughput methods and sophisticated algorithms to design and assemble DNA sequences with greater speed and precision, meeting the demands of researchers and industry for reliable and high-quality synthetic DNA constructs.

- **Increasing Research in Synthetic Biology:**

Synthetic biology involves the design and construction of biological systems and organisms for various applications, such as biopharmaceutical production, biofuel generation, and environmental remediation. This research requires custom DNA constructs tailored to specific functions, which can be efficiently produced through gene synthesis services. Synthetic biology aims to engineer biological systems with novel functions or enhanced capabilities. Researchers design genetic circuits, pathways, and whole genomes to achieve desired traits like improved metabolic efficiency or the production of valuable compounds. Gene synthesis also enables the assembly of complex DNA constructs necessary for these engineering efforts.

- **Rising Demand for Personalized Medicine:**

Personalized medicine aims to tailor medical treatments to individual patient characteristics, including their genetic makeup. Gene synthesis plays a crucial role in developing customized therapies, such as gene therapies and personalized cancer treatments, by enabling the creation of DNA constructs designed to target specific genetic mutations or variations. Advancements in genomics are facilitating the identification of genetic factors underlying various diseases and conditions. Gene synthesis is used to manufacture DNA probes, primers, and other components for genomic diagnostic tests, allowing healthcare providers to assess the genetic predisposition of individuals to certain diseases, select appropriate treatments, and monitor treatment responses.

**Leading Companies Operating in the Global Gene Synthesis Industry:**

- ATUM
- Boster Biological Technology
- Eurofins Genomics
- Genewiz Inc. (Azenta Life Sciences)
- Genscript Biotech Corp.
- Integrated DNA Technologies Inc.
- Merck KGaA
- OriGene Technologies Inc.
- ProMab Biotechnologies Inc.
- ProteoGenix Inc
- Thermo Fisher Scientific Inc.
- Twist Bioscience

**Ask Analyst for Sample Report:** <https://www.imarcgroup.com/request?type=report&id=7159&flag=C>

**Gene Synthesis Market Report Segmentation:**

**By Method:**

- Solid-Phase Synthesis
- Chip-Based Synthesis
- PCR-Based Enzyme Synthesis

Solid-phase synthesis is the largest segment due to its scalability, cost-effectiveness, and ability to synthesize long DNA sequences efficiently.

**By Services:**

- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others

Antibody DNA synthesis accounts for the majority of the market share owing to the increasing demand for customized antibodies in research, diagnostics, and therapeutic applications.

**By Application:**

- Gene and Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Others

Gene and cell therapy development exhibit clear dominance in the market, driven by the growing focus on developing innovative gene and cell-based therapies for treating various diseases, driving the demand for custom DNA constructs.

**By End Use:**

- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Contract Research Organizations

Academic and government research institutes hold the biggest market share as they are significant contributors to basic research, applied sciences, and translational medicine, requiring gene synthesis services for a wide range of research projects.

**Regional Insights:**

- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa

North America enjoys the leading position in the gene synthesis market on account of the presence of a robust biotechnology and pharmaceutical industry, strong research infrastructure, supportive regulatory environment, and high adoption rate of advanced biotechnological tools and techniques.

**Global Gene Synthesis Market Trends:**

There is a rise in the demand for custom DNA constructs across various sectors, including biopharmaceuticals, agriculture, industrial biotechnology, and academic research, driven by the expanding applications of synthetic biology and genetic engineering. With the growing emphasis on personalized medicine and precision healthcare, there is an increase in the demand for gene synthesis services to support the development of personalized therapies, genomic diagnostics, and pharmacogenomics research.

Moreover, the increasing development of gene and cell therapy due to advancements in gene editing technologies like CRISPR-Cas9 and increasing investments from biotech companies and research institutions is strengthening the growth of the market.

**Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.**

**About Us:**

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

**Contact US**

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
